Benitec Biopharma Ltd ADR (BNTC) revenue breakdown
By product, Royalty revenue is the largest at 96% of fiscal 2020 revenue, growing -49% a year over 1 years.
Revenue by product
Fiscal years, as Benitec Biopharma Ltd ADR reports them in its 10-K filings; fiscal 2020 total $97,000.
| Products | 2019 | 2020 | Share |
|---|---|---|---|
| Royalty revenue | $183,000 | $93,000 | 96% |
| Service revenue | $1M | $4,000 | 4% |
| Licensing revenue | $10M | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BNTC.
Open BNTC in InvestinglyQuestions
Where does Benitec Biopharma Ltd ADR make its money?
In fiscal 2020, by product: Royalty revenue $93,000, Service revenue $4,000.
From Benitec Biopharma Ltd ADR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.